CPRX - Catalyst Pharmaceuticals Inc - Growth Ability - Financial Analysis

Growth Ability - Recent 8 Quarters

Numbers in millions	Revenue	Operating Income	Net Income	Pretax Margin	EPS	Revenue Growth Rate YOY	Revenue Growth Rate Avg of 2 Quarters	Revenue Growth Rate QoQ	EPS Growth Rate YOY	EPS Growth Rate Avg of 2 Quarters	EPS Growth Rate QoQ	Net Margin Growth Rate YOY	Net Margin Growth Rate QoQ
2024-06	122	54	40	33.24%	0.33	23.24%	19.32%	24.6%	0.0%	-13.46%	73.68%	-12.34%	40.67%
2024-03	98	27	23	23.63%	0.19	15.39%	48.69%	-10.93%	-26.92%	6.15%	-37.97%	-31.78%	-25.01%
2023-12	110	41	34	31.51%	0.31	81.99%	N/A	7.8%	39.23%	N/A	N/A	-24.83%	N/A
2023-09	102	-37	-30	-29.99%	-0.29	N/A	N/A	3.01%	N/A	N/A	N/A	N/A	N/A
2023-06	99	46	37	37.92%	0.33	N/A	N/A	16.67%	N/A	N/A	26.92%	N/A	9.47%
2023-03	85	35	29	34.64%	0.26	N/A	N/A	40.48%	N/A	N/A	18.18%	N/A	-17.37%
2022-12	60	30	25	41.92%	0.22	N/A	N/A	N/A	N/A	N/A	10.0%	N/A	5.49%
2022-09	0	0	0	39.74%	0.2

Growth Ability - Recent 5 Years

Numbers in millions	Revenue	Operating Income	Net Income	Pretax Margin	EPS	Revenue Growth Rate	Operating Income Growth Rate	Net Income Growth Rate	Net Margin Growth Rate	EPS Growth Rate
2023-12	398	86	71	17.93%	0.63	85.95%	-14.73%	-14.05%	-53.78%	-16.0%
2022-12	214	101	83	38.79%	0.75	29.74%	41.17%	44.21%	11.16%	N/A
2022-09	165	72	57	34.9%	N/A	17.2%	37.65%	45.91%	24.5%	N/A
2021-12	140	52	39	28.03%	0.37	18.29%	26.89%	-47.35%	-55.49%	-47.89%
2020-12	119	41	74	62.97%	0.71

Disclaimer

All the information on the website is for reference only. If the user trades according to this information, he/she shall be responsible for any transaction loss. This website is not responsible for any errors in the content of the information or delay in updating.